Liminatus Pharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $24.7M | $5.4M | — |
| FY2025 | $10.3M | $512.8K | — |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $24.7M | $5.4M | — |
| FY2025 | $10.3M | $512.8K | — |